Melanoma panel provides more tumor information: Ruifeng (Ray) Guo, M.D., Ph.D.

from Answers from the Lab · host Mayo Clinic Laboratories

(00:32) Could you provide a little bit of background about yourself?(01:43) Could you give a brief overview of the new melanoma assay?(04:53) Is the assay able to provide diagnostic, prognostic and classification information, and potential therapeutic implications?(05:12) Could you talk a little more about the MSI assessment in this panel? (05:59) Which patients should have this testing?(07:01) How are these results used in patient care?(08:39) Is there anything else you'd like to add?

Episode metadata supplied by the publisher feed · Published Nov 1, 2022

Embed this episode

Attribution link and audio player

What this episode covers

Ruifeng (Ray) Guo, M.D., Ph.D., explains how Mayo Clinic Laboratories' expanded melanoma panel can enhance patient care. The updated assay provides more comprehensive genomic coverage to better classify melanoma tumors and guide treatment decisions.

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Melanoma panel provides more tumor information: Ruifeng (Ray) Guo, M.D., Ph.D.

0:00 11:08

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Answers from the Lab?

This episode is 11 minutes long.

When was this Answers from the Lab episode published?

This episode was published on November 1, 2022.

Can I download this Answers from the Lab episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!